Cover Image
市場調查報告書

MediPoint:切片設備 - 全球市場的分析與預測

MediPoint: Biopsy Devices - Global Analysis and Market Forecasts

出版商 GlobalData 商品編碼 296803
出版日期 內容資訊 英文 129 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:切片設備 - 全球市場的分析與預測 MediPoint: Biopsy Devices - Global Analysis and Market Forecasts
出版日期: 2016年04月01日 內容資訊: 英文 129 Pages
簡介

癌症,由於無法控制體內異常細胞的增生,可能影響許多器官和組織。當懷疑患者有特定的癌症,透過生檢法(切片檢查),抽出組織學檢驗目標的組織樣品。

本報告提供全球切片設備市場相關調查分析、產業概要、競爭評估、未滿足需求、開發中產品相關驗證、企業簡介、市場預測與預測等,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 產業概要

  • 切片檢查的種類
  • 切片檢查方法趨勢
  • 針對癌症診察計劃的市場進入
  • 法規的問題/回收
  • M&A/主要的夥伴關係
  • 癌症診察、治療的經濟影響
  • 切片設備的適應追加

第4章 未滿足需求

  • 概要
  • 前列腺癌的有效率診察
  • 乳癌的有效率診察
  • 甲狀腺癌的有效率診察
  • 能提供組織學分析的診察

第5章 市場機會分析

  • 歐洲各國的真空協助切片檢查(VAB)設備市場
  • 套組解決方案
  • 中國的VAB設備採用的增加
  • 歐洲的前列腺癌檢驗市場

第6章 推動市場要素和機會

  • 推動市場要素
  • 市場障礙

第7章 競爭評估

  • 概要
  • 基於系統的分類

第8章 開發平台評估

  • 概要

第9章 臨床試驗分析

第10章 現在/未來的主要企業

  • 企業策略趨勢
  • 企業簡介

第11章 市場預測

  • 企業的市場佔有率
  • 各市場區隔
  • 各地區

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0224MAR

Cancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body.

The biopsy devices market is segmented by cancer indication and by the type of biopsy procedure performed. Beyond providing a general analysis and forecast for each device segment in different global regions from 2013-2022, this report offers a more detailed approach by assessing the adoption patterns of the different biopsy procedure types for specific cancer indications in specific geographies. This report and forecast focus on the adoption patterns of biopsy guns, fine needle aspiration (FNA) devices, core needle biopsy (CNB) devices, and vacuum-assisted biopsy (VAB) devices, as well as biopsy forceps and punches in the diagnosis of breast, prostate, lung, liver, colorectal, and thyroid cancers.

Highlights

Key Questions Answered

  • What are the procedure volumes for different biopsy procedures in different countries? How will the volumes change in the next five years?
  • Growth in the biopsy devices market is driven by an increasing number of cancer incident cases. What are the current numbers of cancer diagnosed cases in different geographies? How will the numbers change in the upcoming years?
  • Biopsy guns are most frequently used biopsy devices and core needle biopsy devices gain popularity over fine needle aspiration devices. What are the current adoption trends of different types of biopsy device in different geographies? How will the adoption trends evolve in the near future?
  • There are various types of biopsy devices and different companies have a different strategic product focus. Who are the leading players in the biopsy devices market?

Reasons to buy

  • "What Do Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Overview
  • 2.2. Catalyst
  • 2.3. Related Reports

3. Industry Overview

  • 3.1. Types of Biopsies
    • 3.1.1. Surgical Biopsy
    • 3.1.2. Fine Needle Aspiration
    • 3.1.3. Core Needle Biopsy
    • 3.1.4. Vacuum-Assisted Biopsy
  • 3.2. Market Access to Cancer Screening Programs
    • 3.2.1. Regulation
    • 3.2.2. Biopsy Device Adoption Patterns
    • 3.2.3. Reimbursement Trends
    • 3.2.4. Regulatory Issues/Recalls
  • 3.3. Mergers and Acquisitions/Key Partnerships
    • 3.3.1. Devicor Medical Products Acquires Breast Care Portfolio from Ethicon Endo-Surgery
    • 3.3.2. Argon Medical Devices Acquires Promex Technologies
    • 3.3.3. GTCR Sells Devicor Medical Products
    • 3.3.4. Becton Dickinson Completes Acquisition of CareFusion
  • 3.4. Economic Impact of Cancer Screening and Treatment
  • 3.5. Additional Indications for Biopsy Devices

4. Unmet Needs and Market Opportunity Analysis

  • 4.1. Overview
  • 4.2. Minimise Prostate Biopsy Complications
  • 4.3. More Efficient Screening Tests for Cancer
  • 4.4. More Efficient Screening Guidelines for Thyroid Cancer
  • 4.5. Less Invasive Screening Tests With Better Accuracy

5. Competitive Assessment

  • 5.1. Company Share Analysis
    • 5.1.1. Vacuum-Assisted Biopsy Market Share
    • 5.1.2. Core Needle Biopsy/Fine Needle Aspiration Market Share
  • 5.2. Classification Based on System
    • 5.2.1. Vacuum-Assisted Biopsy Devices
    • 5.2.2. Core Needle Biopsy Devices
    • 5.2.3. Fine Needle Aspiration Devices
  • 5.3. Major Players
    • 5.3.1. Argon Medical Devices
    • 5.3.2. Becton, Dickinson and Company
    • 5.3.3. Boston Scientific
    • 5.3.4. Cook Medical
    • 5.3.5. C. R. Bard
    • 5.3.6. Gallini Medical Devices
    • 5.3.7. Hologic
    • 5.3.8. Leica Biosystems
    • 5.3.9. Stryker
    • 5.3.10. TSK Laboratory
    • 5.3.11. Zamar Care
  • 5.4. Pipeline Products Assessment
    • 5.4.1. Overview
    • 5.4.2. Optical Biopsy
    • 5.4.3. Liquid Biopsy
  • 5.5. Emerging Players

6. Market Outlook

  • 6.1. Biopsy Procedure Trends
    • 6.1.1. Global
    • 6.1.2. US
    • 6.1.3. 5EU
    • 6.1.4. Asia-Pacific Region
    • 6.1.5. South America
  • 6.2. Market Drivers and Barriers
    • 6.2.1. Market Drivers
    • 6.2.2. Market Barriers
  • 6.3. Market Outlook by Segment
    • 6.3.1. Fine Needle Aspiration
    • 6.3.2. Core Needle Biopsy
    • 6.3.3. Vacuum-Assisted Biopsy
    • 6.3.4. Biopsy Guns
    • 6.3.5. Biopsy Forceps and Punches
  • 6.4. Market Outlook by Geography
    • 6.4.1. Global
    • 6.4.2. US
    • 6.4.3. France
    • 6.4.4. Germany
    • 6.4.5. Italy
    • 6.4.6. Spain
    • 6.4.7. UK
    • 6.4.8. Japan
    • 6.4.9. Brazil
    • 6.4.10. China
    • 6.4.11. India

7. Appendix

  • 7.1. Bibliography
  • 7.2. Abbreviations
  • 7.3. Report Methodology
    • 7.3.1. Overview
    • 7.3.2. Coverage
    • 7.3.3. Primary Research
    • 7.3.4. Secondary Research
    • 7.3.5. Forecasting Methodology
  • 7.4. Key Opinion Leaders Included in This Study
  • 7.5. About the Authors
    • 7.5.1. Yizhe Xu, MSc, Research Analyst, Medical Devices
    • 7.5.2. Linda Tian, MSc, Managing Analyst, Medical Devices
    • 7.5.3. Tyler Fletcher, Global Head of Medical Devices
  • 7.6. About MediPoint
  • 7.7. About GlobalData
  • 7.8. Disclaimer

List of Tables

  • Table 1: VAB, Global Market Share, 2015
  • Table 2: CNB/FNA, Global Market Share, 2015
  • Table 3: Company Profile - Argon Medical Devices
  • Table 4: Argon Medical Devices, SWOT Analysis, 2016
  • Table 5: Product Portfolio - Argon Medical Devices
  • Table 6: Company Profile - BD
  • Table 7: BD, SWOT Analysis, 2016
  • Table 8: Product Portfolio - BD
  • Table 9: Company Profile - Boston Scientific
  • Table 10: Boston Scientific SWOT Analysis, 2016
  • Table 11: Product Portfolio - Boston Scientific
  • Table 12: Company Profile - Cook Medical
  • Table 13: Cook Medical, SWOT Analysis, 2016
  • Table 14: Product Portfolio - Cook Medical
  • Table 15: Company Profile - C. R. Bard
  • Table 16: C. R. Bard, SWOT Analysis, 2016
  • Table 17: Product Portfolio - C. R. Bard
  • Table 18: Company Profile - Gallini Medical Devices
  • Table 19: Gallini Medical Devices SWOT Analysis, 2016
  • Table 20: Product Portfolio - Gallini Medical Devices
  • Table 21: Company Profile - Hologic
  • Table 22: Hologic SWOT Analysis, 2016
  • Table 23: Product Portfolio - Hologic
  • Table 24: Company Profile - Leica Biosystems
  • Table 25: Leica Biosystems, SWOT Analysis, 2016
  • Table 26: Product Portfolio - Leica Biosystems
  • Table 27: Company Profile - Stryker
  • Table 28: Sktryker SWOT Analysis, 2016
  • Table 29: Product Portfolio - Stryker
  • Table 30: Company Profile - TSK Laboratory
  • Table 31: TSK Laboratory SWOT Analysis, 2016
  • Table 32: Product Portfolio - TSK Laboratory
  • Table 33: Company Profile - Zamar Care
  • Table 34: Zamar Care SWOT Analysis, 2016
  • Table 35: Product Portfolio - Zamar Care
  • Table 36: Emerging Players in Liquid Biopsy Market
  • Table 37: Global Biopsy Procedure Volume, 2013-2022
  • Table 38: Age Demographics, Age >65 Years, Global, 2013
  • Table 39: Global FNA Device Sales ($m) Forecast, 2013-2022
  • Table 40: Global CNB Device Sales ($m) Forecast, 2013-2022
  • Table 41: Global VAB Device Sales ($m) Forecast, 2013-2022
  • Table 42: Global Biopsy Guns Sales ($m) Forecast, 2013-2022
  • Table 43: Global Biopsy Forceps and Punches Sales ($m) Forecast, 2013-2022
  • Table 44: Global Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Table 45: Global Biopsy Devices Sales Unit, 2013-2022
  • Table 46: Global Biopsy Devices Sales Unit by device type, 2013-2022
  • Table 47: US Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Table 48: France Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Table 49: Germany Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Table 50: Italy Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Table 51: Spain Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Table 52: UK Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Table 53: Japan Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Table 54: Brazil Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Table 55: China Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Table 56: India Biopsy Devices Sales ($m) Forecast, 2013-2022

List of Figures

  • Figure 1 : Biopsy Devices, Global Market Share, 2015
  • Figure 2: VAB, Global Market Share, 2015
  • Figure 3: CNB/FNA, Global Market Share, 2015
  • Figure 4: Global Biopsy Procedure Volume: All Indications, 2013-2022
  • Figure 5: Biopsy Procedure Volume: All Indications, US, 2013-2022
  • Figure 6: Biopsy Procedure Volumes: Prostate, 5EU, 2013-2022
  • Figure 7: Biopsy Procedure Volume: Breast, 5EU, 2013-2022
  • Figure 8: Biopsy Procedure Volume: Lung, 5EU, 2013-2022
  • Figure 9: Biopsy Procedure Volume: Colorectal, 5EU, 2013-2022
  • Figure 10: Biopsy Procedure Volumes: Liver, 5EU, 2013-2022
  • Figure 11: Biopsy Procedure Volume: Thyroid, 5EU, 2013-2022
  • Figure 12: Biopsy Procedure Volume: Prostate, APAC Region, 2013-2022
  • Figure 13: Biopsy Procedure Volume: Breast, APAC Region, 2013-2022
  • Figure 14: Biopsy Procedure Volume: Lung, APAC Region, 2013-2022
  • Figure 15: Biopsy Procedure Volume: Colorectal, APAC Region, 2013-2022
  • Figure 16: Biopsy Procedure Volume: Liver, APAC Region, 2013-2022
  • Figure 17: Biopsy Procedure Volume: Thyroid, APAC Region, 2013-2022
  • Figure 18: Biopsy Procedure Volume: All Cancer Indications, Brazil, 2013-2022
  • Figure 19: Global FNA Device Sales ($m) Forecast, 2013-2022
  • Figure 20: Global CNB Device Sales ($m) Forecast, 2013-2022
  • Figure 21: Global VAB Device Sales ($m) Forecast, 2013-2022
  • Figure 22: Global Biopsy Guns Sales ($m) Forecast, 2013-2022
  • Figure 23: Global Biopsy Forceps and Punches Sales ($m) Forecast, 2013-2022
  • Figure 24: Global Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Figure 25: Global Biopsy Devices Sales ($m) share by country, 2015 and 2022
  • Figure 26: US Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Figure 27: France Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Figure 28: Germany Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Figure 29: Italy Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Figure 30: Spain Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Figure 31: UK Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Figure 32: Japan Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Figure 33: Brazil Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Figure 34: China Biopsy Devices Sales ($m) Forecast, 2013-2022
  • Figure 35: India Biopsy Devices Sales ($m) Forecast, 2013-2022
Back to Top